MAM
Mudra Max appoints Anwesh Bose as branch head-North & East
MUMBAI:Mudra Max has appointed Anwesh Bose as its branch head for North and East.
Prior to this appointment he was with the Dentsu India Group as chief growth officer-media.
Said Mudra Connext EVP and country head Manas Mishra, “With Anwesh we have a seasoned media professional with experience in the Delhi market. His experience with the many national and international brands, the partnerships he has built with media and clients will all help us in further strengthening our operation in Delhi and Kolkata. We welcome him on board and wish him a long and successful inning.”
Bose added, “I am delighted to be a part of the Mudra family and excited with the prospects of Mudra Max. Mudra Max is now at a very exciting stage in its journey and I look forward to being part of it at such a momentous time.”
Bose has been in the media planning and buying industry for over 13 years. He started his career in 1998 and has worked with brands such as Yamaha, Honda, Suzlon, Canon, Grasim, Jaypee, Daikin, Raymond, Toyota, Panasonic, FedEx and Thomas Cook.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
